4//SEC Filing
Cavalier Jason 4
Accession 0000950170-24-115594
CIK 0001327273other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:05 PM ET
Size
5.2 KB
Accession
0000950170-24-115594
Insider Transaction Report
Form 4
Cavalier Jason
Chief Financial Officer
Transactions
- Award
Common Stock
2024-10-16+100,000→ 100,000 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three substantially equal installments occurring on April 1, 2025, October 1, 2025 and April 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001883290
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:05 PM ET
- Size
- 5.2 KB